GammaDelta Therapeutics
0 followers
‌
GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells to create improved immunotherapy of cancer and other serious diseases. The company plans to exploit unique properties of tissue resident γδ T cells for effective immunotherapy.
Industries
+2
Headquarters
Employees
Links
Org chart
Paolo Paoletti, MD
Collapse
Juan-Jose Guijarro-Leach
Head of Analytical Development
Sandra Van Wetering
VP Process Science and Manufacturing
Emma Roffe
Director
